Marksans Pharma Limited — Investor Meet, 30-01-2025: Analysts/Institutional Investor Meet/Con. Call Updates

The Company has scheduled a conference call on February 12, 2025, at 05:30 PM IST to discuss the financial results for the quarter ended December 31, 2024. Key topics for discussion will likely include insights into the earnings performance, growth strategies, and potential market dynamics affecting future operations. Participants can expect insights from senior management, including the Founder and MD, and the Chief Financial Officer. The call is expected to provide a platform for investors and analysts to gain clarity on financial metrics and management's outlook moving forward.